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multidisciplinary unit at a tertiary teaching hospital.
Methods: 1030 patients with hip fracture underwent troponin measurement, electrocardiogram and
echocardiogram at admission, 24 and 48 h after surgery. Exclusion criteria were age b 70 years, severe aortic ste-
nosis, myocardial infarction b30 days, stress cardiomyopathy, renal failure, sepsis, active neoplastic disease. End-
points were 30-day and 1 year mortality.
Results: Troponin I levels ≥0.5 μg/l were found in 129/1030. 37 of them were excluded according to reported
criteria. In the 92 patients included in the study in hospital and 1 year mortality were significantly higher than
in controls (12.5% vs 3.5%, p .0012 and respectively 44% vs 16.1% at 12 months, p b .001). 18 patients underwent
coronary angiography within 1 week from hip surgery. All had multivessel coronary artery disease. One patient
died after angiography. At multivariate logistic analysis age (OR 1.09, 95% CI = 1.01 to 1.19, p= .044) and creat-
inine values (OR= 7. 55, 95% CI= 1.26 to 45.3, p= .02) were independent predictive factors of 1 year mortality
whereas coronary revascularization (OR= 0.15, 95% CI = 0.03 to 0.78, p = .024) was an independent factor as-
sociated with improved survival.
Conclusions: Perioperative TnI elevation is associatedwith a significantly increase in 30-day and 1-yearmortality.
Severe coronary disease may be suspected in patients with perioperative myocardial infarction after hip fracture
surgery. Our study is one of the first providing data on the safety and feasibility of early (inhospital) coronary
angiograpy and PCI after hip surgery. Further studies are needed to establish indication of coronary angiography
in these patients.
© 2018 Published by Elsevier B.V.Keywords:
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Outcome1. Introduction
The incidence of perioperative acute myocardial infarction (MI) in
hip fracture has been reported between 6 and 33% [1–2]. Most patients
are asymptomatic and diagnosis is made on the basis of ECG changes
and/or troponin increase [3–5]. About 70% of perioperative myocardial
infarctions occur after surgery while in the remaining 30% diagnosis is
made already at hospital admission. This latter group has more fre-
quently a history of previous coronary artery disease [6]. Although
criteria suggested by the third universal diagnosis of myocardialand Regione Toscana - RF-2010-
enze, Italy.infarction should be used [7], with few exceptions [8] diagnosis has
been made essentially on the basis of increased troponin values
[3–5,9]. Even small troponin increases, above upper 99th percentile of
a normal reference population, has been associated with prolonged hos-
pitalization and,more relevant,with increased in-hospital and long-term
mortality [3,7]. Several clinical conditions associatedwith a poor progno-
sis such sepsis, pulmonary embolism, renal failure and acute respiratory
failure may cause isolated troponin increase. This may be a confounding
factor in the pathophysiological interpretation of perioperative bio-
marker increase [10–11]. Troponin I measurements N0.5 μg/l have been
consideredmarkers of definitemyocardial damage [2] and a relationship
between higher values and poor prognosis has been clearly reported
[2,12]. ST elevation myocardial infarction occurs in b3% of patients and
the most of perioperative myocardial infarctions are referred as type 2
myocardial infarction. Nevertheless at present none of the published
Fig. 1. Flowchart of patients enrolled in the study.
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Intervention in patients with troponin elevation after emergency ortho-
pedic surgery has been essentially limited to intensive post-operative
monitoring [13]. Recently the inMANAGE trial [14] patientswith postop-
erative troponin elevation after noncardiac surgery were treated using
110 mg of dabigatran twice daily. A 28% reduction in vascular events
was demonstrated at 16 months without an increase in major bleeding.
A multidisciplinary team for patients with hip fracture exists in Univer-
sity Hospital Careggi Florence since January 2102. The goal of this
group was to stratify the risk before surgery, guide the anesthesiology
strategy, prevent and treat early complications of surgery, decrease peri-
operative mortality and improve life expectancy and quality of life [15].
Aim of this study was to evaluate incidence, clinical characteristics,
post surgical management strategy, including early coronary angiogra-
phy, in patients with significant troponin increase (N0,5 μg/l) after hip
fracture. In-hospital and 1-year survival are also reported.2. Methods
An observational prospective study was conducted at the University Hospital Careggi
in Florence, Italy. The study is part of a project of Italian Health Ministry and Regione
Toscana - RF-2010-2316600 - and was approved by the Ethical Committee of Regione
Toscana. At admission all patients gave signed informed consent to collect and analyze
clinical data for research purposes. The study protocol conforms to the ethical guidelines
of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's
human research committee.
For the preparation of the manuscript the STROBE guidelines were followed. Recruit-
ment occurred between January 2013 and December 2015 and included all consecutive
patients admitted to our hospital with diagnosis of hip fracture. At hospital admission,
all patients with hip fracture underwent orthopedic examination and radiological investi-
gation, venous line positioning, ECG, laboratory examinations including troponin I assay,
and chest X-ray. Troponin and ECG were repeated at the end of surgery and thereafter at
12, 24 and 48 h. Echocardiography was performed in all patients before surgery and re-
peated within 48 h in all patients with troponin changes. In the study were included pa-
tients with perioperative troponin increase and a cut off value ≥0.5 μg/l was used to
assess definite myocardial damage in order to increase specificity and limit the risk to in-
clude troponin increase due to conditions not related to ischemic injury [2,12]. The highest
valuewas reported for statistical analysis. ECG abnormalities suggestingmyocardial ische-
mia such as ST elevation or depression andfinally typical Twave changeswere considered.
Newly recorded left wall motion abnormalities or abnormalities consistent with ECG
changes in absence of prior examinations were considered suggestive of ischemic
myocardial damage. Exclusion criteria were age b 70 years, severe aortic stenosis
(aortic valve area b 1.0 cm2), recent myocardial infarction (b30 days), acute stress cardio-
myopathy diagnosed according to Mayo clinic criteria [15], renal failure (creatinine clear-
ance b20 ml/min), sepsis, active neoplastic disease and conservative treatment (Fig. 1).
Coronary angiography was proposed to patients who had a chance of recovery, on the
basis of preoperative functional and cognitive conditions, and inwhoma decreased life ex-
pectancy other than impaired quality of life was expected due to coronary artery disease.
The degree of cognitive impairmentwas assessed using the The Short PortableMental Sta-
tus Questionnaire (SPMSQ) [16] Functional capacity before trauma was evaluated using
Barthel scale [17]. End point of the study were 30-day and 1-year mortality.
All patients included in the study were treated with aspirin 100 mg/day. Dual anti-
platelet therapy (aspirin 100 mg and clopidogrel 75 md daily) was prescribed in patients
underwent percutaneous coronary revascularization. Patients in atrialfibrillation resumed
ongoing anticoagulant treatment 4–5 days after hip surgery, low molecular weight hepa-
rin was administered as full bridge therapy or at DVT prophylactic dose according to the
risk profile in patients with AF. Three patients underwent coronary revascularization re-
sumed warfarin with ongoing dual antiplatelet therapy. LMWH at DVT prophylactic
dose was prosecuted for at least 35 days in patients in sinus rhythm. After percutaneous
revascularization major bleeding was evaluated according to criteria proposed by the In-
ternational Society of Thrombosis and Haemostasis [18].2.1. Statistical analysis
Categorical variables are reported as frequency and percentage. Values for continuous
variables were given as the mean (±SD). Categorical variables were compared using the
χ2 test or the Fisher exact test. Thirty six patients comparable for age, sex, left ventricular
ejection fraction and without cognitive impairment were matched in a 2:1 ratio with the
18 patients underwent coronary angiography. Two-tailed Kaplan-Meier curveswere used
for the survival analysis. Differences between groups were compared using Log-Rank test.
After the univariate analyses, a logisticmultivariable regression analysiswas performed to
identify independent predictors for mortality. Because of multiple testing, only variable
with a two-sided p b .05 in the univariate analysis were accepted for themodel. Statistical
analysis was performed with the use of the SPSS statistical software program (SPSS Inc.,
Chicago, IL, USA). A probability value of b.05 was considered to be statistically significant.3. Results
1030 consecutive patients with hip fracture were referred to the
Trauma Centre of the University Hospital Careggi Florence between
January 1st 2013 and December 31st 2015. Following the criteria re-
ported in the Methods section, 105 patients were excluded from the
study (37 had increased troponin levels). The study group was com-
posed by 92 patients (63 women and 29 men, mean age 86.7 ±
7.8 years) who had at least one perioperative troponin level ≥ 0.5 μg/l
suggesting definite myocardial damage. One third of them had a TnI
increase already at hospital admission. The remaining 832 patients
became the control group. Among these 134 patients recalled
retrospectively from electronic medical records had minor TnI increase
(0.10–0.49 μg/l). In these patients in hospitalmortalitywas 4.9% not sig-
nificantly higher than in patients without troponin increase.
Clinical characteristics of patients are reported in Table 1. History of
coronary artery disease, diabetesmellitus, peripheral artery diseasewas
significantly more frequent in patients with perioperative myocardial
infarction than in controls. Hip surgery was performed within 48 h
from hospital admission in 54/92 (59.3%) of patients in study group in
comparison to 594/832 (66%) of control group. Blood losses were not
different in the two groups.
In our study 18 out of 92 patients underwent early coronary angiog-
raphy. The procedurewas performed during hospitalization, on average
within 4 days after hip surgery. All patients were found to have severe
coronary disease (stenosis ≥70% of two or three major epicardial ves-
sels, proximal LAD was involved in 18/18 patients). Patients referred
for coronary angiography were younger (81.9 vs 87.5 years, p = .02)
and had no significant cognitive impairment (SPMSQ with b5 errors:
0/18 vs 29/74, p = .05). The two groups did not differ with regard to
gender, history of ischemic heart disease, hypertension, peripheral vas-
cular disease or diabetes mellitus, LVEF and finally pulmonary artery
pressure. Electrocardiographic and/or echocardiographic abnormalities
were not significantly more frequent in patients referred for angiogra-
phy (15/18–82% vs 594/832–66%). Creatinine values were significantly
lower in patients underwent angiography. One patient with 90% ostial
left main stenosis died of refractory asystole during the procedure. No
other complications were observed, in particular we did not find any
significant bleeding from the orthopedic surgical site neither major
bleeding according to the International Society of Thrombosis and
Haemostasis criteria [18]. Percutaneous revascularization was per-
formed at the end of diagnostic procedure in 15 patients while 2
underwent surgical revascularization within two weeks.
11 of the 92 patients (12.5%) died during hospitalization in compar-
ison to 30/832 (3.5%) in control group (p= .003). Theywere older (89.4
vs 86.4 years), however the difference was not statistically significant.
Similarly a higher mortality trend was found in males (50% vs 32%).
Cognitive impairment was related to a significantly higher mortality
Table 1
Clinical characteristics of patients included in the study.
AMI
n = 92
Controls
n = 832
p
Male/female (%) 31 29 ns
Mean age (SD) 86.7 (8.8) 84.0 (8,0) .0017
Time to surgery b 48 h (%) 59.9 66 ns
Preoperative Hb (g/dl) 11.8 ± 1.5 11.6 ± 1.8 ns
Post-operative Hb (g/dl) 9.3 ± 1.4 9.4 ± 1.5 ns
Length of hospitalization
(days) mean (SD)
14.4 (6) 13.1 (3.4) .0012
CAD (%) 34 15.7 b.0001
Heart failure (%) 13 7 ns
Diabetes (%) 38 8 b.0001
Hypertension (%) 72 63 ns
Dementia (SPMSQ N 5 errors) (%) 34 32 ns
Atrial fibrillation (%) 15 8 .021
Peripheral vascular disease (%) 30 4 b.0001 Fig. 2. Survival in control group, patients undergone coronary revascularization patients
treated with medical therapy and overall survival after perioperative AMI.
Table 2
Case – control comparison between patients underwent or not to coronary angiography.
Case (n = 18) Controls (n = 36) p
M/F (%) 70 69 .92
Age mean (SD) 85 + 8 86 + 5 .71
Peak preoperative TnI (mg/dl) median 0.74 0.50 .86
Peakpostoperative TnI (mg/dl) median 1.530 1.395 .55
Preoperative Hb (g/dl) 11.8 ± 0.9 11.9 ± 1.6 .80
Post-operative Hb (g/dl) 9.6 ± 1.3 9.5 ± 1.6 .81
RBC transfusion (%) 61 56 .77
LVEF 50 ± 6 51 ± 8 .64
Pulmonary artery pressure (mm Hg) 38 ± 13 35 ± 11 .37
Creatinine (mg/dl) 0.9 ± 0.3 1.0 ± 0.3 .25
B-blockers, (%) 88 91 .76
Aspirin, (%) 100 94 .68
AT1/ACE inhibitors, (%) 72 26 .23
Statins, (%) 88 72 .60
Oral anticoagulants, (%) 16 25 .74
CAD, (%) 38 30 .73
Diabetes, (%) 38 36 .50
Hypertension, (%) 70 63 .36
Peripheral artery disease, (%) 36 32 .75
Atrial fibrillation, (%) 16 22 .66
1 year mortality (%) 27 56 .041
AT1= angiotensin 1 receptor blockers, ACE= angiotensin converting enzyme inhibitors,
CAD = coronary artery disease, LVEF = left ventricle ejection fraction.
3C. Rostagno et al. / International Journal of Cardiology 284 (2019) 1–5(p = .003). Finally serum creatinine concentrations were higher in pa-
tients who died during hospitalization.
Thirty-five out of 81 patients (44%)with perioperativemyocardial in-
farction that were discharged alive from hospital died at one-year in
comparison to 133/832 (16.1%) of control group (p b .0001). Death in
study group was cardiac in 32 patients, non-cardiac in 9 (3 related to
late septic complications, 3 to stroke, 3 to other causes). We did not
find significant differences in long-term survival between patients with
or without ECG and/or echocardiographic ischemic changes. None of pa-
tients discharged alive fromhospital underwent invasive evaluation dur-
ing follow-up period. 13/16 patients (81%) that underwent coronary
angiography and revascularization in the early postoperative period
after hip fracture were alive at one year follow-up in comparison to 31/
65 (42%) treated with medical therapy alone (Fig. 2). Multivariate
logistic analysis showed that both in the whole population and in pa-
tients discharged alive after surgery age (OR = 1.09, 95% CI = 1.01 to
1.19, p = .044 and respectively OR = 1.11, 95% CI = 1.01 to 1.22, p =
.041) and creatinine values (OR = 7.55, 95% CI = 1.26 to 45.3, p = .02
and respectively OR= 4.88, 95% CI= 1.04 to 22.94, p= .04) were inde-
pendent predictive factors of 1 yearmortalitywhereas coronary revascu-
larization (OR = 0.15, 95% CI = 0.03 to 0.78, p = .024 and respectively
OR = 0.06, 95% CI = 0.02 to 0.72, p = .026) was an independent factor
associated with improved survival. Only in patients discharged alive
fromhospital a preserved cognitive functionwas associatedwith a better
outcome (OR = 0.21, 95% CI = 0.05 to 0.89, p = .034).
A case–control matching was made to better understand the effects
of coronary revascularization. Thirty six patients comparable for age,
sex, left ventricular ejection fraction and without cognitive impairment
were matched in a 2:1 ratio with the 18 patients underwent coronary
revascularization. At 1 year survival were respectively 73% in patients
underwent coronary revascularization and 44% in those who did not.
No significant differences were found between the two groups regard-
ing other parameters considered (Table 2).
4. Discussion
Troponin increase, even after adjustment for confounding factors,
has been demonstrated to be an independent risk factor for early and
long term mortality as well as for longer hospital stay and higher need
for institutionalization [12,19–21]. The relationship between troponin
increase and myocardial damage however has been questioned by
some authors [8,12,21].
According to different diagnostic criteria the incidence of periopera-
tive acute myocardial infarction in patients hospitalized for hip fracture
varies from 6 to 35% [1,12,21]. The diagnosis of perioperative myocar-
dial infarction is often underestimated since most patients are asymp-
tomatic and diagnosis is made on the basis of ECG changes and/or
troponin assay [2,19–23]. Moreover, in these patients perioperativemyocardial infarction was often the first clinical manifestation of coro-
nary heart disease.
In a retrospective study from Olmsted County, Minnesota [3] inci-
dence of perioperative myocardial infarction was 13.8% among 1212
consecutive patients admitted for hip fracture, Most events occurred
in the first 48 h after surgery. In-hospital mortality was 14.4% while 1-
year survival was 60.5%. The majority of patients did not experience is-
chemic symptoms and cardiac biomarkers were required for the
diagnosis.
Hietala et al. [4] observed an increase of TnT in 35.5% of patients with
hip fracture. Nearly half of thesepatients showed troponin increase before
surgery. A troponin T increase N0.15 μg/l was also predictive of 30-day
mortality (24% v 17% in patients with smaller troponin increases). In
this study increase of troponin was the only independent predictor of
30-day mortality. Fisher et al. [12] showed that a perioperative increase
of troponin IN 0.06 μg/lwas an independent determinant of length of hos-
pital stay and need for long term residential care facilities. A troponin I N 1
μg/l was predictor of all-causemortalitywith 98% specificity and 89%neg-
ative predictive value. Recently Vallet et al. [8] reported that patientswith
acute coronary syndrome, diagnosed on the basis of ECG changes associ-
atedwith troponin increase, but not thosewith isolated troponin rise had
poor long term prognosis after hip fracture surgery. A six month com-
bined end-point of death and/or re-hospitalization was found in 44% of
acute coronary syndrome patients in comparison to 29% in patients
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study, only 1 patient with acute coronary syndrome underwent coronary
angiography. Few investigation evaluated the effects of cardiology inter-
vention, essentially limited to intensive post-operative monitoring.
Chong et al. [13] did not find any significant difference in 1 yearmortality
between patients were randomized to cardiology care versus standard
ward management. Multivariate predictors of 1 year mortality were
post-operative troponin elevation OR 4.3 (95% CI, 1.1–16.4, p = .035),
age OR 1.1 (95% CI, 1.02–1.2, p = .016) and number of comorbidities
OR 2.1 (95% CI, 1.3–3.5, p = .004). Recently MANAGE trial [14] random-
ized 1754 patients with postoperative troponin elevation after non-
cardiac surgery to dabigatran 110 mg twice daily or placebo. At a
follow-up of 16 months, dabigatran induced a significant reduction of a
composite end-point (occurrence of a major vascular complication, a
composite of vascular mortality and non-fatal myocardial infarction,
non-hemorrhagic stroke, peripheral arterial thrombosis, amputation,
and symptomatic venous thromboembolism). Mean age was 45 years,
33% had orthopedic surgery finally an history of coronary disease was
present in 14% at enrollment. Only 14 patients (b1%) underwent coronary
angiography.
Surgical treatment of hip fracture within 48 h from trauma has been
reported to be associated with lower mortality, higher probability of
functional recovery and decrease of complication rate associated with
prolonged immobilization [23–25].
Overall one third of patients had a significant increase of troponin al-
ready at hospital admission [4]. Although ESC and AHA/ACC guidelines
on cardiovascular assessment and treatment in non-cardiac surgery
suggest that urgent treatment should not be deferred in patients with
acute coronary syndromes [24–26] there are no data regarding the
need for clinical stabilization in high risk patients with hip fracture
and preoperative troponin increase.
Results from the present study from a multidisciplinary hip fracture
team showed a 9.6% incidence of perioperative myocardial infarction. A
cut-off value of troponin I (≥0.5 μg/l), suggestive of definite myocardial
damage [2,12], was used to increase sensitivity and specificity of the di-
agnosis. Thismay account for the lower incidence of perioperativemyo-
cardial in comparison to other studies [22–24]. In hospital and 1 year
mortality were significantly higher in patients with troponin increase
than in controls (12.5% vs 3.5%, p = .0012 and 44% vs 16.1%, p b .0001,
respectively). We did not find long-term survival differences between
patients with or without ECG and/or echocardiographic ischemic
changes and our data confirm that myocardial damage assessed by in-
creased biomarker levels is an independent poor prognostic factor in
patient undergoing hip fracture surgery.
At present ESC or AHA/ACC guidelines do not provide any suggestion
about early invasive evaluation in patients with perioperative myocar-
dial infarction after non-cardiac surgery [27–28]. Despite the demonstra-
tion of a clear relation between decreased long term survival and
troponin increase after hip fracture surgery and other non cardiac surgi-
cal procedure, it is still debated the pathophysiological mechanism re-
lated to troponin increase (ischemic or non-ischemic cause). None of
these studies however evaluated coronary anatomy. Several mecha-
nisms may favor cardiac damage in the perioperative period [29–30],
but the demonstration of critical lesions in all patients undergoing coro-
nary angiography in our study may suggest that myocardial necrosis is
mainly associated with severe multivessel coronary artery disease thus
justifying the poor long-term outcome. In patients discharged alive
after revascularization mortality at 1 year was lower than 20%, however
our investigation was not addressed to demonstrate the absolute bene-
fits of coronary revascularization after perioperative myocardial infarc-
tion, since the study did not have numerical power. The main purpose
of present paper was to evaluated the feasibility and safety of early cor-
onary angiography in patients with perioperative myocardial infarction
after hip fracture surgery in order to clear still debated pathophysiologic
mechanisms. We acknowledge that a selection bias is likely since coro-
nary angiography was avoided in frail patients, defined as subjectswith moderate to severe functional and cognitive impairment, patients
with a poor prognosis irrespective of the presence and treatment of cor-
onary artery disease. However a case controlmatching, inwhich patients
with cognitive impairment were excluded from analysis, confirmed the
different survival rates between the two groups. Therefore results from
present investigation may be useful to open a discussion about the
proper management of perioperative myocardial infarction in non-
cardiac surgery.
5. Limitations of the study
The main limit of present study is the small number of enrolled pa-
tients. In particular only 20% underwent early coronary angiography.
Therefore results do not allow to draw strong conclusions. On the other
hand the finding that all patients undergoing coronary angiography had
multivessel coronary artery disease, a data never reported before, may
give useful pathophysiological information and offer indications to design
further studies. Although the population included in the study is a high
risk elderly group, N25% may be successfully revascularized with im-
provement in quality of life and life expectancy. The effects of coronary re-
vascularization on survival are effectively weakened by a selection bias
and need confirmation by large multicenter registries. More information
are required also on the safety of the procedure. Further studies, including
randomized studies, may allow to identify clinical criteria for an early in-
vasive strategy in patients with perioperative myocardial infarction after
hip surgery. Another point to be outlined is that although even small
troponin increases have been related with increased in-hospital and
long-term mortality, in our prospective study an arbitrary cut off value
≥0.5 μg/l was used in order to limit the risk to include troponin increase
due to conditions not related to ischemic injury [2,12].
6. Conclusions
Perioperativemyocardial infarction ascertained by significant tropo-
nin increase is associated with a poor in hospital and long term progno-
sis in patients undergoing surgery for hip fracture. When coronary
angiography was performed severe multivessel disease was consis-
tently present. Early invasive treatment with percutaneous revasculari-
zation might significantly improve long term survival in selected
patients. Further studies are needed to assess the indications to an
early invasive strategy in patients with perioperative MI after surgery
for hip fracture.
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